| Article ID | Journal | Published Year | Pages | File Type | 
|---|---|---|---|---|
| 5584791 | Practical Laboratory Medicine | 2017 | 8 Pages | 
Abstract
												These results describe the relationship between granulocyte and neutrophil counts, measured on a laboratory analyser, in a large population of patients with malignancies and receiving anti-cancer therapies. However, this relationship must be established using a point of care testing system with a three-part differential count before considering the possibility that a granulocyte count can guide clinical decisions in the absence of a definitive neutrophil count, to reduce the frequency and severity of neutropenic complications in patients receiving cancer treatments.
											Related Topics
												
													Life Sciences
													Biochemistry, Genetics and Molecular Biology
													Clinical Biochemistry
												
											Authors
												Nicola S. Pether, Jessica L. Brothwood, Cornelis van Berkel, Elaine H. Dunwoodie, Robert L. Blake, Christopher P. Price, Richard G. Jones, Karl S. Baker, Geoff Hall, 
											